Silk Technologies Ltd.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2013-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.silk-tech.com
Study to Evaluate the Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED) (SDP-4-CS202)
Phase 2
Completed
- Conditions
- Dry Eye
- Interventions
- Drug: VehicleDrug: SDP-4 Ophthalmic Solution (1.0%)
- First Posted Date
- 2020-09-02
- Last Posted Date
- 2022-09-01
- Lead Sponsor
- Silk Technologies, Ltd.
- Target Recruit Count
- 153
- Registration Number
- NCT04535947
- Locations
- 🇺🇸
Orange County Ophthalmology Medical Group, Garden Grove, California, United States
🇺🇸LoBue Laser and Eye Medical Center, Murrieta, California, United States
🇺🇸Eye Research Foundation, Newport Beach, California, United States
Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED)
Phase 2
Completed
- Conditions
- Dry Eye
- Interventions
- Drug: SDP-4 Ophthalmic Solution (1.0%)Drug: VehicleDrug: SDP-4 Ophthalmic Solution (3.0%)Drug: SDP-4 Ophthalmic Solution (0.1%)
- First Posted Date
- 2019-03-26
- Last Posted Date
- 2022-09-02
- Lead Sponsor
- Silk Technologies, Ltd.
- Target Recruit Count
- 305
- Registration Number
- NCT03889886
- Locations
- 🇺🇸
Canyon City Eyecare, Azusa, California, United States
🇺🇸Eye Research Foundation, Newport Beach, California, United States
🇺🇸Eye Associates of Fort Myers, Fort Myers, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath